80/100B160.420
USD
-2.88
(-1.76%)
Pre Open
Last updated: · Delayed 15 min
Fair value128.72Plus+25%103Price 160.42634
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Novartis current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Novartis's current ratio is 0.88: current assets of 28.75B USD against current liabilities of 32.53B USD due within a year.
- Today
- 0.88
- Average, 5 years
- 1.06
- Low, 5 years
- 0.79
- High, 5 years
- 1.51
Current ratio = current assets ÷ current liabilities = 28.75B ÷ 32.53B = 0.88
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 0.88 | 28.75B | 32.53B | |
| FY2025 | 31 Dec 2025 | 1.12 | 30.46B | 27.28B |
| FY2024 | 31 Dec 2024 | 1.04 | 29.70B | 28.69B |
| FY2023 | 31 Dec 2023 | 1.16 | 30.48B | 26.39B |
| FY2022 | 31 Dec 2022 | 1.29 | 36.91B | 28.66B |
| FY2021 | 31 Dec 2021 | 1.51 | 45.72B | 30.21B |
| FY2020 | 31 Dec 2020 | 0.90 | 29.67B | 33.06B |
| FY2019 | 31 Dec 2019 | 1.04 | 29.50B | 28.26B |
| FY2018 | 31 Dec 2018 | 1.20 | 35.56B | 29.61B |
| FY2017 | 31 Dec 2017 | 1.21 | 28.21B | 23.40B |
| FY2016 | 31 Dec 2016 | 1.12 | 24.93B | 22.21B |
| FY2015 | 31 Dec 2015 | 0.96 | 22.85B | 23.71B |
| FY2014 | 31 Dec 2014 | 1.39 | 37.56B | 26.97B |
| FY2013 | 31 Dec 2013 | 1.16 | 30.54B | 26.37B |
| FY2012 | 31 Dec 2012 | 1.16 | 28.00B | 24.05B |
| FY2011 | 31 Dec 2011 | 1.04 | 24.08B | 23.15B |
| FY2010 | 31 Dec 2010 | 1.08 | 26.69B | 24.66B |
| FY2009 | 31 Dec 2009 | 1.73 | 33.69B | 19.47B |
| FY2008 | 31 Dec 2008 | 1.27 | 20.88B | 16.50B |
| FY2007 | 31 Dec 2007 | 1.65 | 27.43B | 16.64B |
| FY2006 | 31 Dec 2006 | 1.32 | 21.40B | 16.23B |
| FY2005 | 31 Dec 2005 | 1.40 | 21.44B | 15.33B |
| FY2004 | 31 Dec 2004 | 2.22 | 24.61B | 11.08B |
| FY2003 | 31 Dec 2003 | 2.39 | 22.27B | 9.32B |
| FY2002 | 31 Dec 2002 | 2.52 | 20.87B | 8.29B |
| FY2001 | 31 Dec 2001 | 2.40 | 20.64B | 8.59B |
| FY2000 | 31 Dec 2000 | 2.83 | 20.08B | 7.10B |
| FY1999 | 31 Dec 1999 | 1.99 | 21.81B | 10.95B |
| FY1998 | 31 Dec 1998 | 2.01 | 21.16B | 10.55B |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.88 | 28.75B | 32.53B |
| Q2 FY2026 | 30 Jun 2026 | 0.86 | 27.35B | 31.75B |
| Q1 FY2026 | 31 Mar 2026 | 0.85 | 26.61B | 31.37B |
| Q4 FY2025 | 31 Dec 2025 | 1.12 | 30.46B | 27.28B |
| Q3 FY2025 | 29 Sept 2025 | 0.88 | 28.20B | 32.00B |
| Q2 FY2025 | 30 Jun 2025 | 0.82 | 25.94B | 31.71B |
| Q1 FY2025 | 31 Mar 2025 | 0.79 | 25.11B | 31.62B |
| Q4 FY2024 | 31 Dec 2024 | 1.04 | 29.70B | 28.69B |
| Q3 FY2024 | 30 Sept 2024 | 1.11 | 31.26B | 28.13B |
| Q2 FY2024 | 30 Jun 2024 | 0.93 | 25.69B | 27.61B |
| Q1 FY2024 | 31 Mar 2024 | 0.90 | 26.45B | 29.29B |
| Q4 FY2023 | 31 Dec 2023 | 1.16 | 30.48B | 26.39B |
| Q3 FY2023 | 30 Sept 2023 | 0.94 | 45.66B | 48.39B |
| Q2 FY2023 | 30 Jun 2023 | 1.05 | 33.49B | 31.91B |
| Q1 FY2023 | 31 Mar 2023 | 1.05 | 32.11B | 30.55B |
| Q4 FY2022 | 31 Dec 2022 | 1.29 | 36.91B | 28.66B |
| Q3 FY2022 | 30 Sept 2022 | 1.31 | 36.95B | 28.16B |
| Q2 FY2022 | 30 Jun 2022 | 1.38 | 38.14B | 27.65B |
| Q1 FY2022 | 31 Mar 2022 | 1.25 | 37.24B | 29.81B |
| Q4 FY2021 | 31 Dec 2021 | 1.51 | 45.72B | 30.21B |
| Q3 FY2021 | 30 Sept 2021 | 0.88 | 26.25B | 29.88B |
| Q2 FY2021 | 30 Jun 2021 | 0.80 | 23.81B | 29.63B |
| Q1 FY2021 | 31 Mar 2021 | 0.74 | 22.20B | 30.16B |
| Q4 FY2020 | 31 Dec 2020 | 0.90 | 29.67B | 33.06B |
| Q3 FY2020 | 30 Sept 2020 | 0.91 | 28.97B | 31.84B |
| Q2 FY2020 | 30 Jun 2020 | 0.81 | 23.88B | 29.38B |
| Q1 FY2020 | 31 Mar 2020 | 0.74 | 23.10B | 31.29B |
| Q4 FY2019 | 31 Dec 2019 | 1.04 | 29.50B | 28.26B |
| Q3 FY2019 | 30 Sept 2019 | 0.95 | 26.68B | 28.22B |
| Q2 FY2019 | 30 Jun 2019 | 0.94 | 28.32B | 30.11B |
| Q1 FY2019 | 31 Mar 2019 | 0.93 | 52.45B | 56.13B |
| Q4 FY2018 | 31 Dec 2018 | 1.20 | 35.56B | 29.61B |
| Q3 FY2018 | 30 Sept 2018 | 1.20 | 34.11B | 28.33B |
| Q2 FY2018 | 30 Jun 2018 | 1.15 | 32.07B | 27.94B |
| Q1 FY2018 | 31 Mar 2018 | 1.17 | 33.05B | 28.22B |
| Q4 FY2017 | 31 Dec 2017 | 1.21 | 28.21B | 23.40B |
| Q3 FY2017 | 30 Sept 2017 | 1.08 | 27.47B | 25.38B |
| Q2 FY2017 | 30 Jun 2017 | 1.01 | 26.54B | 26.15B |
| Q1 FY2017 | 31 Mar 2017 | 0.98 | 25.77B | 26.33B |
| Q4 FY2016 | 31 Dec 2016 | 1.12 | 24.93B | 22.21B |
| Q3 FY2016 | 30 Sept 2016 | 1.05 | 25.88B | 24.60B |
| Q2 FY2016 | 30 Jun 2016 | 0.90 | 23.72B | 26.27B |
| Q1 FY2016 | 31 Mar 2016 | 0.83 | 22.99B | 27.82B |
| Q4 FY2015 | 31 Dec 2015 | 0.96 | 22.85B | 23.71B |
| Q3 FY2015 | 30 Sept 2015 | 0.85 | 24.05B | 28.16B |
| Q2 FY2015 | 30 Jun 2015 | 0.84 | 24.75B | 29.39B |
| Q1 FY2015 | 31 Mar 2015 | 0.88 | 25.71B | 29.05B |
| Q4 FY2014 | 31 Dec 2014 | 1.39 | 37.56B | 26.97B |
| Q3 FY2014 | 30 Sept 2014 | 1.38 | 36.79B | 26.62B |
| Q2 FY2014 | 30 Jun 2014 | 1.27 | 34.97B | 27.56B |
| Q1 FY2014 | 31 Mar 2014 | 1.20 | 29.69B | 24.76B |
| Q4 FY2013 | 31 Dec 2013 | 1.16 | 30.54B | 26.37B |
| Q3 FY2013 | 30 Sept 2013 | 1.11 | 28.77B | 25.81B |
| Q2 FY2013 | 30 Jun 2013 | 1.10 | 26.85B | 24.39B |
| Q1 FY2013 | 31 Mar 2013 | 1.02 | 26.80B | 26.37B |
| Q4 FY2012 | 31 Dec 2012 | 1.16 | 28.00B | 24.05B |
| Q3 FY2012 | 30 Sept 2012 | 1.20 | 26.15B | 21.86B |
| Q2 FY2012 | 30 Jun 2012 | 1.05 | 26.12B | 24.92B |
| Q1 FY2012 | 31 Mar 2012 | 0.94 | 25.79B | 27.36B |
| Q4 FY2011 | 31 Dec 2011 | 1.04 | 24.08B | 23.15B |
| Q3 FY2011 | 30 Sept 2011 | 0.99 | 25.56B | 25.83B |
| Q2 FY2011 | 30 Jun 2011 | 0.90 | 26.63B | 29.54B |
| Q1 FY2011 | 31 Mar 2011 | 0.90 | 29.10B | 32.22B |
| Q4 FY2010 | 31 Dec 2010 | 1.08 | 26.69B | 24.66B |
| Q3 FY2010 | 30 Sept 2010 | 1.00 | 27.72B | 27.66B |
| Q2 FY2010 | 30 Jun 2010 | 2.17 | 38.67B | 17.83B |
| Q1 FY2010 | 31 Mar 2010 | 2.05 | 35.80B | 17.43B |
| Q4 FY2009 | 31 Dec 2009 | 1.73 | 33.69B | 19.47B |
| Q3 FY2009 | 30 Sept 2009 | 1.70 | 30.44B | 17.90B |
| Q2 FY2009 | 30 Jun 2009 | 1.77 | 27.17B | 15.36B |
| Q1 FY2009 | 31 Mar 2009 | 1.50 | 22.48B | 14.99B |
| Q4 FY2008 | 31 Dec 2008 | 1.27 | 20.88B | 16.50B |
| Q3 FY2008 | 30 Sept 2008 | 1.17 | 23.30B | 19.95B |
| Q2 FY2008 | 30 Jun 2008 | 1.63 | 32.09B | 19.68B |
| Q1 FY2008 | 31 Mar 2008 | 1.54 | 26.29B | 17.06B |
| Q4 FY2007 | 31 Dec 2007 | 1.65 | 27.43B | 16.64B |
| Q3 FY2007 | 30 Sept 2007 | 1.64 | 28.68B | 17.50B |
| Q2 FY2007 | 30 Jun 2007 | 1.29 | 20.64B | 15.98B |
| Q1 FY2007 | 31 Mar 2007 | 1.22 | 21.33B | 17.55B |
| Q4 FY2006 | 31 Dec 2006 | 1.32 | 21.40B | 16.23B |
| Q3 FY2006 | 30 Sept 2006 | 1.29 | 20.97B | 16.32B |
| Q2 FY2006 | 30 Jun 2006 | 1.18 | 19.80B | 16.76B |
| Q1 FY2006 | 31 Mar 2006 | 1.41 | 21.92B | 15.59B |
| Q4 FY2005 | 31 Dec 2005 | 1.40 | 21.44B | 15.33B |
| Q3 FY2005 | 30 Sept 2005 | 1.48 | 18.48B | 12.46B |
| Q2 FY2005 | 30 Jun 2005 | 1.59 | 20.11B | 12.64B |
| Q1 FY2005 | 31 Mar 2005 | 1.97 | 22.26B | 11.32B |
| Q4 FY2004 | 31 Dec 2004 | 2.22 | 24.61B | 11.08B |
| Q3 FY2004 | 30 Sept 2004 | 2.40 | 21.56B | 8.98B |
| Q2 FY2004 | 30 Jun 2004 | 2.41 | 21.63B | 8.99B |
| Q1 FY2004 | 31 Mar 2004 | 2.25 | 21.21B | 9.42B |
| Q4 FY2003 | 31 Dec 2003 | 2.39 | 22.27B | 9.32B |
| Q3 FY2003 | 30 Sept 2003 | 2.46 | 20.52B | 8.35B |
| Q2 FY2003 | 30 Jun 2003 | 2.05 | 20.16B | 9.82B |
| Q1 FY2003 | 31 Mar 2003 | 2.29 | 21.88B | 9.54B |
| Q4 FY2002 | 31 Dec 2002 | 2.52 | 20.87B | 8.29B |
| Q3 FY2002 | 30 Sept 2002 | 2.19 | 18.12B | 8.28B |
| Q2 FY2002 | 30 Jun 2002 | 2.56 | 20.76B | 8.12B |
| Q1 FY2002 | 31 Mar 2002 | — | — | — |
| Q4 FY2001 | 31 Dec 2001 | 2.40 | 20.64B | 8.59B |
| Q3 FY2001 | 30 Sept 2001 | — | — | — |
| Q2 FY2001 | 30 Jun 2001 | 1.92 | 15.62B | 8.13B |
| Q1 FY2001 | 31 Mar 2001 | — | — | — |
| Q4 FY2000 | 31 Dec 2000 | 2.83 | 20.08B | 7.10B |
| Q3 FY2000 | 30 Sept 2000 | — | — | — |
| Q2 FY2000 | 30 Jun 2000 | 2.60 | 23.22B | 8.94B |
| Q1 FY2000 | 31 Mar 2000 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,All ratios
Common questions about Novartis's current ratio
Source: Financial Modeling Prep